Mood symptoms in steroid users: the unexamined role of concurrent stimulant use

References

• Bagatell, C. J., Heiman, J. R., Matsumoto, A. M., Rivier, J. E., & Bremner, W. J. (1994). Metabolic and behavioral effects of high-dose, exogenous testosterone in healthy men. The Journal of Clinical Endocrinology & Metabolism, 79, 561–567
   PubMed Web of Science ®Google Scholar
• Bahrke, M. S., Wright, J. E., Strauss, R. H., & Catlin, D. H. (1992). Psychological moods and subjectively perceived behavioral and somatic changes accompanying anabolic-androgenic steroid use. The American Journal of Sports Medicine, 20, 717–724
   PubMed Web of Science ®Google Scholar
• Bents, R. T., Tokish, J. M., & Goldberg, L. (2004). Ephedrine, pseudoephedrine, and amphetamine prevalence in college hockey players: most report performance-enhancing use. The Physician and Sports Medicine, 32, 30–34
   PubMed Web of Science ®Google Scholar
• Blanck, H., Khan, L., & Serdula, M. K. (2001). Use of nonprescription weight loss products: Results from a multistate survey. JAMA, 286, 930–935
   PubMed Web of Science ®Google Scholar
• Buckman, J. F., Farris, S. G., & Yusko, D. A. (2013). A national study of substance use behaviors among NCAA male athletes who use banned performance enhancing substances. Drug and Alcohol Dependence, 131, 50–55
   PubMed Web of Science ®Google Scholar
• Chantal, Y., Soubranne, R., & Brunel, P. C. (2009). Exploring the social image of anabolic steroids users through motivation, sportspersonship orientations and aggression. Scandinavian Journal of Medicine & Science in Sports, 19, 228–234
   PubMed Web of Science ®Google Scholar
• Choi, P. Y., Parrott, A. C., & Cowan, D. (1990). High-dose anabolic steroids in strength athletes: Effects upon hostility and aggression. Human Psychopharmacology: Clinical and Experimental, 5, 349–356
   Google Scholar
• Choi, P. Y., & Pope, H. G. (1994). Violence toward women and illicit androgenic-anabolic steroid use. Annals of Clinical Psychiatry, 6, 21–25
   PubMedGoogle Scholar
• Coffey, C. S., Steiner, D., Baker, B. A., & Allison, D. B. (2004). A randomized double-blind placebo-controlled clinical trial of a product containing ephedrine, caffeine, and other ingredients from herbal sources for treatment of overweight and obesity in the absence of lifestyle treatment. International Journal of Obesity, 28, 1411–1419
   PubMed Web of Science ®Google Scholar
• Cooke, R. G., Krüger, S., & Shugar, G. (1996). Comparative evaluation of two self-report mania rating scales. Biological Psychiatry, 40, 279–283
   PubMed Web of Science ®Google Scholar
• Cooper, C. J., Noakes, T. D., Dunne, T., Lambert, M. I., & Rochford, K. (1996). A high prevalence of abnormal personality traits in chronic users of anabolic-androgenic steroids. British Journal of Sports Medicine, 30, 246–250
   PubMed Web of Science ®Google Scholar
• Crowne, D. P., & Marlowe, D. (1960). A new scale of social desirability independent of psychopathology. Journal of Consulting Psychology, 24, 349–354
   PubMedGoogle Scholar
• Daly, R. C., Su, T. P., Schmidt, P. J., Pagliaro, M., Pickar, D., & Rubinow, D. R. (2003). Neuroendocrine and behavioral effects of high-dose anabolic steroid administration in male normal volunteers. Psychoneuroendocrinology, 28, 317–331
   PubMed Web of Science ®Google Scholar
• Dodge, T., & Hoagland, M. F. (2011). The use of anabolic androgenic steroids and polypharmacy: A review of the literature. Drug and Alcohol Dependence, 114, 100–109
   PubMed Web of Science ®Google Scholar
• Hildebrandt, T., Harty, S., & Langenbucher, J. W. (2012). Fitness supplements as a gateway substance for anabolic-androgenic steroid use. Psychology of Addictive Behaviors, 26, 955–962
   PubMed Web of Science ®Google Scholar
• Hildebrandt, T., Langenbucher, J., Carr, S., Sanjuan, P., & Park, S. (2006). Predicting intentions for long-term anabolic-androgenic steroid use among men: A covariance structure model. Psychology of Addictive Behaviors, 20, 234–240
   PubMed Web of Science ®Google Scholar
• Hildebrandt, T., Langenbucher, J. W., Carr, S. J., & Sanjuan, P. (2007). Modeling population heterogeneity in appearance- and performance-enhancing drug (APED) use: Applications of mixture modeling in 400 regular APED users. Journal of Abnormal Psychology, 116, 717–733
   PubMed Web of Science ®Google Scholar
• Ingram, R. E., Kendall, P. C., Siegle, G., Guarino, J., & McLaughlin, S. C. (1995). Psychometric properties of the Positive Automatic Thoughts Questionnaire. Psychological Assessment, 7, 495–507
   Web of Science ®Google Scholar
• Ingram, R. E., & Wisnicki, K. S. (1988). Assessment of positive automatic cognition. Journal of Consulting and Clinical Psychology, 56, 898–902
   PubMed Web of Science ®Google Scholar
• Johnston, L. D., O’Malley, P. M., Bachman, J. G., & Schulenberg, J. E. (2012). Monitoring the Future national results on adolescent drug use: Overview of key findings, 2011. Ann Arbor, MI: Institute for Social Research, The University of Michigan
   Google Scholar
• Kanayama, G., Gruber, A. J., Pope, H. G., Jr Borowiecki, J. J., & Hudson, J. I. (2001). Over-the-counter drug use in gymnasiums: An underrecognized substance abuse problem? Psychotherapy and Psychosomatics, 70, 137–140
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Hudson, J. I., & Pope, H. G. (2009). Illicit anabolic–androgenic steroid use. Hormones and Behavior, 58, 111–121
   PubMed Web of Science ®Google Scholar
• Kouri, E. M., Lukas, S. E., Pope, H. G., & Oliva, P. S. (1995a). Increased aggressive responding in male volunteers following the administration of gradually increasing doses of testosterone cypionate. Drug and Alcohol Dependence, 40, 73–79
   PubMed Web of Science ®Google Scholar
• Kouri, E. M., Pope, H. G., Katz, D. L., & Oliva, P. (1995b). Fat-free mass index in users and nonusers of anabolic-androgenic steroids. Clinical Journal of Sport Medicine, 5, 223–228
   PubMed Web of Science ®Google Scholar
• Lefavi, R. G., Reeve, T. G., & Newland, M. C. (1990). Relationship between anabolic steroid use and selected psychological parameters in male bodybuilders. Journal of Sport Behavior, 13, 157–166
   Google Scholar
• Maglione, M., Miotto, K., Iguchi, M., Jungvig, L., Morton, S. C., & Shekelle, P. G. (2005). Psychiatric effects of ephedra use: An analysis of food and drug administration reports of adverse events. The American Journal of Psychiatry, 162, 189–191
   PubMed Web of Science ®Google Scholar
• Malone, D. A., Dimeff, R. J., Lombardo, J. A., & Sample, R. H. (1995). Psychiatric effects and psychoactive substance use in anabolic-androgenic steroid users. Clinical Journal of Sport Medicine, 5, 25–31
   PubMed Web of Science ®Google Scholar
• McNair, D. M., & Heuchert, J. W. P. (2005). Profile of Mood States: Technical Update. North Tonawanda, NY: Multi-Health Systems, Inc
   Google Scholar
• Midgley, S. J., Heather, N., & Davies, J. B. (2001). Levels of aggression among a group of anabolic-androgenic steroid users. Medicine, Science and the Law, 41, 309–314
   PubMed Web of Science ®Google Scholar
• Moss, H. B., Panzak, G. L., & Tarter, R. E. (1992). Personality, mood, and psychiatric symptoms among anabolic steroid users. The American Journal on Addictions, 1, 315–324
   Google Scholar
• O’Connor, D. B., Archer, J., & Wu, F. C. W. (2004). Effects of testosterone on mood, aggression, and sexual behavior in young men: A double-blind, placebo-controlled, cross-over study. The Journal of Clinical Endocrinology & Metabolism, 89, 2837–2845
   PubMed Web of Science ®Google Scholar
• Pagonis, T. A., Angelopoulos, N. V., Koukoulis, G. N., & Hadjichristodoulou, C. S. (2006). Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse. European Psychiatry, 21, 551–562
   PubMed Web of Science ®Google Scholar
• Parrott, A. C., Choi, P. Y., & Davies, M. (1994). Anabolic steroid use by amateur athletes: Effects upon psychological mood states. The Journal of Sports Medicine and Physical Fitness, 34, 292–298
   PubMed Web of Science ®Google Scholar
• Pearce, C. J., & Himsworth, R. L. (1982). Thyrotoxicosis factitia. The New England Journal of Medicine, 307, 1708–1709
   PubMed Web of Science ®Google Scholar
• Perry, P. J., Kutscher, E. C., Lund, B. C., Yates, W. R., Holman, T. L., & Demers, L. (2003). Measures of aggression and mood changes in male weightlifters with and without androgenic anabolic steroid use. Journal of Forensic Sciences, 48, 646–651
   PubMed Web of Science ®Google Scholar
• Pope H. G. Jr, Kouri E. M., & Hudson J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men: A randomized controlled trial. Archives of General Psychiatry, 57, 133–140
   PubMed Web of Science ®Google Scholar
• Pope, H. G., & Katz, D. L. (1988). Affective and psychotic symptoms associated with anabolic steroid use. The American Journal of Psychiatry, 145, 487–490
   PubMed Web of Science ®Google Scholar
• Pope, H. G., & Katz, D. L. (1994). Psychiatric and medical effects of anabolic-androgenic steroid use: A controlled study of 160 athletes. Archives of General Psychiatry, 51, 375–382
   PubMed Web of Science ®Google Scholar
• Rubinow, D. R., & Schmidt, P. J. (1996). Androgens, brain, and behavior. The American Journal of Psychiatry, 153, 974–984
   PubMed Web of Science ®Google Scholar
• Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014). The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of Epidemiology, 24, 383–398
   PubMed Web of Science ®Google Scholar
• Shekelle, P. G., Hardy, M. L., Morton, S. C., et al. (2003). Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: A meta-analysis. JAMA, 289, 1537–1545
   PubMed Web of Science ®Google Scholar
• Shugar, G., Schertzer, S., Toner, B. B., & di Gasbarro, I. (1992). Development, use, and factor analysis of a self-report inventory for mania. Comprehensive Psychiatry, 33, 325–331
   PubMed Web of Science ®Google Scholar
• Sjöqvist, F., Garle, M., & Rane, A. (2008). Use of doping agents, particularly anabolic steroids, in sports and society. The Lancet, 371, 1872–1882
   PubMed Web of Science ®Google Scholar
• Spielberger, C. D. (1998). The State-Trait Anger Expression Inventory, revised (STAXI-2). Odessa, FL: Psychological Assessment Resources, Inc
   Google Scholar
• Su, T., Pagliaro, M., Schmidt, P. J., Pickar, D., Wolkowitz, O., & Rubinow, D. R. (1993). NEuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA, 269, 2760–2764
   PubMed Web of Science ®Google Scholar
• Tricker, R., Casaburi, R., Storer, T. W., Clevenger, B., Berman, N., Shirazi, A., & Bhasin, S. (1996). The effects of supraphysiological doses of testosterone on angry behavior in healthy eugonadal men–A clinical research center study. The Journal of Clinical Endocrinology & Metabolism, 81, 3754–3758
   PubMed Web of Science ®Google Scholar
• Watson, D., Clark, L. A., & Tellegen, A. (1988). Development and validation of brief measures of positive and negative affect: The PANAS scales. Journal of Personality and Social Psychology, 54, 1063–1070
   PubMed Web of Science ®Google Scholar
• Yates, W. R., Perry, P. J., MacIndoe, J., Holman, T., & Ellingrod, V. (1999). Psychosexual effects of three doses of testosterone cycling in normal men. Biological Psychiatry, 45, 254–260
   PubMed Web of Science ®Google Scholar
• Yates, W. R., Perry, P., & Murray, S. (1992). Aggression and hostility in anabolic steroid users. Biological Psychiatry, 31, 1232–1234
   PubMed Web of Science ®Google Scholar
• Yeun, E. J., & Shin-Park, K. K. (2006). Verification of the Profile of Mood States-Brief: Cross-cultural analysis. Journal of Clinical Psychology, 62, 1173–1180
   PubMed Web of Science ®Google Scholar